Specifications table {#s0005}
====================

TableSubject areaBiologyMore specific subject areaMurine auditory brainstem responses (ABRs)Type of dataExternal text (txt.) fileHow data was acquiredABR set up (TDT)Data formatRaw dataExperimental factorsFemale and male Ca~v~2.3^+/+^, Ca~v~2.3^+/-^ and Ca~v~2.3^-/-^ mice were anesthetized using ketamine/xylazine. Subsequently, click and tone-burst evoked ABRs were recorded using a commercially available ABR setup from TDT.Experimental featuresABR recordings from age-matched female and male Ca~v~2.3^+/+^, Ca~v~2.3^+/-^ and Ca~v~2.3^-/-^ mice.Data source locationBonn, GermanyData accessibilityData is available at (MENDELEY DATA, DIO: 〈[DOI:10.17632/g6ygz2spzx.1](http://dx.doi.org/10.17632/g6ygz2spzx.1){#ir0007}〉, URL: 〈<https://data.mendeley.com/datasets/g6ygz2spzx/1>〉)

Value of the data {#s0010}
=================

•These data provide resources for investigation of sex-specific differences in auditory information processing in age-matched controls (Ca~v~2.3^+/+^), heterozygous (Ca~v~2.3^+/-^) and homozygous Ca~v~2.3 null mutants (Ca~v~2.3^-/-^) based on click and tone burst evoked ABRs.•This data collection provides basis for analysis of click and tone-burst related hearing thresholds, amplitude growth function, peak latency analysis etc. via manual or automated tools.•Data is provided in standardized format to ease access and use for multiple purposes.•The publication of this dataset will enable users to benchmark their results for comparison with related auditory data on other voltage-gated Ca^2+^ channels and to postulate novel hypotheses on the role of Ca~v~2.3 in auditory processing.

1. Data {#s0015}
=======

Ca~v~2.3^+/+^, Ca~v~2.3^+/-^ and Ca~v~2.3^-/-^ mice from both genders were anesthetized using ketamine/xylazine. Following injection narcosis, click and tone-burst evoked ABRs were recorded using a standard ABR setup (TDT). As the TDT raw data file format (.arf) requires TDT specific software (see [Section 2.3](#s0035){ref-type="sec"} below) which is not freely available, raw data were exported as text file (.txt) format and are accessible at (MENDELEY DATA, DIO: 〈[DOI:10.17632/g6ygz2spzx.1](http://dx.doi.org/10.17632/g6ygz2spzx.1){#ir0008}〉, URL: 〈<https://data.mendeley.com/datasets/g6ygz2spzx/1>〉).

2. Experimental design, materials and methods {#s0020}
=============================================

2.1. Experimental animals {#s0025}
-------------------------

All experimental genotypes (Ca~v~2.3^+/+^, Ca~v~2.3^+/-^, Ca~v~2.3^-/-^) were generated via heterozygous Ca~v~2.3^+/-^ embryos (kindly provided by Richard j. Miller, Department of Neurobiology, Pharmacology and Physiology, The University of Chicago, Chicago, IL, [@bib1]) which were re-derived with C57BL/6J mice and maintained with random intra-strain mating [@bib2]. A neo-URA3 cassette was used to replace the exons 4--8 of Cacna1e via homologous recombination (Mouse Genome Informatics; MGI Ref. ID J: 66144).

For subsequent ABR recordings, Ca~v~2.3^+/+^ controls, heterozygous Ca~v~2.3^+/-^ and homozygous null mutant Ca~v~2.3^-/-^ mice (58 animals in total, aged 141.29 ± 0.39 days (\~ 20 wks)) from both age-matched genders were used with the following characteristics: Males: Ca~v~2.3^+/+^: *n* = 9 (♂), weight 32.72 ± 1.80 g; Ca~v~2.3^+/-^: *n* = 9 (♂), weight 31.64 ± 1.12 g; Ca~v~2.3^-/-^: *n* = 10 (♂), weight 31.10 ± 0.89 g. Females: Ca~v~2.3^+/+^: *n* = 9 (♀), weight 25.41 ± 0.57 g; Ca~v~2.3^+/-^: *n* = 10 (♀), weight 25.42 ± 1.36 g; Ca~v~2.3^-/-^: *n* = 11 (♀), weight 27.00 ± 0.43 g.

Experimental animals were housed in groups of 3--4 in clear Macrolon cages type II with *ad libitum* access to standard food pellets and drinking water. Mice were maintained at a temperature of 21 ± 2 °C, 50--60% relative humidity, and on a conventional 12 h light/dark cycle with the light cycle starting at 05:00 AM using ventilated cabinets (Type Uniprotect, Bioscape). The animals were strictly acclimatized to this circadian pattern prior to subsequent experimentation. All animal procedures were conducted according to the Guidelines of the German Council on Animal Care and all protocols were approved by the Local Institutional and National Committee on Animal Care (Landesamt für Natur, Umwelt und Verbraucherschutz, State Office of North Rhine-Westphalia, Department of Nature, Environment and Consumerism, LANUV NRW, Germany). The authors further certify that all animal experimentation was performed in accordance with the European Communities Council Directive of November 24, 1986 (86/609/EEC). Specific effort was made to minimize the number of animals used and their suffering.

2.2. Mouse anesthesia {#s0030}
---------------------

Prior to ABR recordings, animals were anesthetized using ketamine (100 mg/kg body weight i.p., Ketanest^®^ S, 25 mg/ml Pfizer, Germany) and xylazine (10 mg/kg body weight i.p., Rompun^®^ 2%, Bayer HealthCare, Germany) and positioned inside a sound attenuating cubicle (ENV-018V, Med Association Inc., USA) lined with an acoustical foam. In addition, the entire sound attenuating cubicle was covered by a Faraday cage (stainless steel, 2 mm thickness, 1 cm mesh size) to protect ABR recordings from electrical noise. To maintain body core temperature, animals were placed on a homeothermic heating blanked (ThermoLux^®^, Witte + Sutor, Germany; TSE^®^, Bad Homburg, Germany) inside the attenuating cubicle. To protect from corneal desiccation, eyes were covered with an eye ointment (5% Dexpanthenol, Bepanthen^®^, Bayer Vital GmbH, Germany) [@bib2].

2.3. ABR recording procedure {#s0035}
----------------------------

For recording of monaural bioelectrical auditory potentials, subdermal stainless steel electrodes (27GA 12 mm, Rochester Electro-Medical, USA) were inserted at the vertex, axial the pinnae (positive (+) electrode) and ventrolateral of the right pinna (negative (-) electrode). The ground electrode was positioned at the hip of the animal. To verify proper electrode positioning/conductivity, impedance measurements of all electrodes (\< 5 kΩ) were carried out prior to each ABR recording [@bib2].

All ABR recordings were performed under free field conditions using a single loudspeaker (MF1 Multi-Function Speaker, Tucker-Davis Technologies Inc., TDT, USA) which was positioned 10 cm opposite to the rostrum of the animals (loudspeaker leading edge perpendicular to the mouse interaural axis).

The SigGenRZ software (Tucker-Davis Technologies Inc., TDT, USA) was utilized to program stimulus protocols for both click and tone bursts. The bioelectrical ABR signals recorded from the subdermal electrodes were transferred to a head stage (RA4LI, Tucker-Davis Technologies Inc., TDT, USA) and forwarded to the preamplifier (RA4PA, Tucker-Davis Technologies Inc., TDT, USA) with 20-fold amplification.

The ABR equipment e.g. loudspeaker control, acoustic stimulus presentation (clicks and tone bursts), ABR acquisition, ABR processing, averaging and data management were further coordinated using the RZ6 Multi I/O Processor system and BioSigRZ software (both Tucker-Davis Technologies Inc., TDT, USA).

Note that ABR data acquisition was performed at a sampling rate of 24.4 kHz and signals were bandpass filtered (low pass 5 kHz, high pass 300 Hz) using a 6-pole Butterworth filter. Importantly, the individual ABR data acquisition time (recording signal architecture) was 25 ms starting with a 5 ms baseline period (preABR baseline), followed by a 10 ms ABR section triggered by the individual acoustic click or tone burst stimulus onset and another, final 10 ms baseline (postABR baseline) [@bib2].

The two types of acoustic stimuli were applied for ABR recordings in Ca~v~2.3^+/+^, Ca~v~2.3^+/-^ and Ca~v~2.3^-/-^ mice using the SigGenRZ software (Tucker-Davis Technologies Inc., TDT, USA) and applied via the TDT BioSigRZ platform. The click stimulus entity was an electrical white noise burst of 100 µs duration, with alternating polarity (switching between condensation and rarefaction) and substantial energy in the 0.8--43 kHz range. The tone burst stimulus entity was a 4.5 ms tone burst (transient sinusoidal plus) of alternating polarity with Hann envelope rise and fall times of 1.5 ms duration. The frequency range covered 1--42 kHz in 6 kHz steps. All acoustic stimuli were repeated 300 times at a rate of 20 Hz for averaging.

For ABR threshold recordings, sound pressure levels (SPL) were increased in 5 dB steps for clicks and 10 dB steps for tone bursts, starting from 0 dB up to 90 dB (increasing SPL mode). Sound pressure levels for tone bursts within the range of 1--42 kHz were calibrated each day prior to recording using a microphone (378C01, PCB Pieztronics Inc., N.Y., U.S.A) connected to a preamplifier (480C02, PCB Pieztronics Inc) and the RZ6 Multi I/O Processor system (Tucker-Davis Technologies Inc, TDT, USA). The microphone was placed inside the sound attenuating cubicle and connected to an oscilloscope (DPO3012, Tektronix^TM^, USA) to monitor and confirm the spectrum of sound stimuli using online Fast Fourier Transformation (FFT) [@bib2].
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